{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:29:45Z","timestamp":1760099385936},"reference-count":44,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2003,7,15]]},"abstract":"<jats:p> Purpose: The prognostic information provided by alpha-fetoprotein and human chorionic gonadotrophin in the management of germ cell tumor (GCT) patients is a biochemical reflection of tumor differentiation. Ki67, p53, and apoptosis have been found to be related to proliferation (Ki67), cell death (p53, apoptosis), and possibly differentiation chemoresistance (p53). We sought to determine whether simultaneous expression of one or more of these markers could identify clinically relevant subgroups of patients with nonseminomatous GCT (NSGCT). <\/jats:p><jats:p> Patients and Methods: These five marker values were obtained for 95 previously untreated patients with embryonal carcinoma with or without other germ cell components. A multivariate cluster analysis was performed to identify patients with similar marker patterns. <\/jats:p><jats:p> Results: One prominent cluster (n = 37; 36 testis retroperitoneum), consisting of 26 (70%) good-risk (GR), nine (24%) intermediate-risk (IR), and two (6%) poor-risk (PR) patients, as defined by the International Germ Cell Consensus Cancer Group (IGCCCG), was observed. The 5-year survival of the prominent cluster (with 30% IR\/PR patients) was 94% (95% confidence interval [CI], 86% to 100%), which is comparable to the 91% (95% CI, 89% to 93%) 5-year survival of the IGCCCG GR patients. IGCCCG risk status (P = .005) and cluster affiliation (P = .04) were independent predictors of outcome with hazard ratios of 5.0 (95% CI, 1.6 to 15.4) and 4.6 (95% CI, 1.04 to 20.1), respectively. <\/jats:p><jats:p> Conclusion: These results suggest that there is a subgroup of NSGCT patients with embryonal carcinoma (with or without other histologies) with a specific tumor biology profile (high Ki67, low apoptosis, and low p53) whose survival is better than that of the overall patient group. The unexpectedly good outcome for the prominent cluster and independent-risk status suggest that subgroups of GCT reflecting different abilities to respond to treatment exist within IGCCCG prognostic categories. <\/jats:p>","DOI":"10.1200\/jco.2003.03.136","type":"journal-article","created":{"date-parts":[[2003,7,14]],"date-time":"2003-07-14T19:35:40Z","timestamp":1058211340000},"page":"2679-2688","source":"Crossref","is-referenced-by-count":24,"title":["Cluster Analysis of p53 and Ki67 Expression, Apoptosis, Alpha-Fetoprotein, and Human Chorionic Gonadotrophin Indicates a Favorable Prognostic Subgroup Within the Embryonal Carcinoma Germ Cell Tumor"],"prefix":"10.1200","volume":"21","author":[{"given":"Madhu","family":"Mazumdar","sequence":"first","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Bacik","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Dobrzynski","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Donadio","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Bajorin","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Motzer","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Reuter","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Bosl","sequence":"additional","affiliation":[{"name":"From the Department of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Division of Solid Tumor Oncology, and Department of Pathology, Memorial Sloan-Kettering Cancer Center; and Departments of Medicine and Pathology, Weill Medical College, Cornell University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707243370406"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.594"},{"key":"R3","unstructured":"Albers P, Orazi A, Ulbright TM, et al: Prognostic significance of immunohistochemical proliferation markers (Ki-67\/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Mod Pathol 8:492,1995\u2013497,"},{"key":"R4","unstructured":"Knudson CM, Johnson GM, Lin Y, et al: Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res 61:659,2001\u2013665,"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Lutzker SG: P53 tumour suppressor gene and germ cell neoplasia. APMIS 106:85,1998\u201389,","DOI":"10.1111\/j.1699-0463.1998.tb01323.x"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201770"},{"key":"R9","unstructured":"Thykjaer T, Workman C, Kruhoffer M, et al: Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61:2492,2001\u20132499,"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(99)00561-8"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.97"},{"key":"R12","unstructured":"Megha T, Lazzi S, Ferrari F, et al: Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: A correlation with cellular kinetics. Anticancer Res 19:163,1999\u2013169,"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.3109\/10520299809140523"},{"key":"R14","unstructured":"Gilks WR, Oldfield L, Wild P: Data analysis of the Second International Workshop on Small Cell Lung Cancer Antigens. Br J Cancer 14:3,1991\u20139,  (suppl)"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951215)76:12<2510::AID-CNCR2820761216>3.0.CO;2-Q"},{"key":"R16","unstructured":"Haroske G, Dimmer V, Steindorf D, et al: Cellular sociology of proliferating tumor cells in invasive ductal breast cancer. Anal Quant Cytol Histol 18:191,1996\u2013198,"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<203::AID-IJC10>3.0.CO;2-0"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810815)48:4<888::AID-CNCR2820480405>3.0.CO;2-D"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810301)47:5<833::AID-CNCR2820470502>3.0.CO;2-H"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830315)51:6<1072::AID-CNCR2820510616>3.0.CO;2-Z"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.10.1493"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.8.1231"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.119.3.493"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(72)90553-4"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"R27","unstructured":"Chaganti RSK, Houldsworth J: Genetics and biology of human germ cell tumors. Cancer Res 60:1475,2000\u20131482,"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.6.1551"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204394"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2388(199709\/10)13:5<319::AID-SSU5>3.0.CO;2-G"},{"key":"R31","unstructured":"Bosl GJ, Reuter V, Mazumdar M, et al: Significant differences in Ki67, p53 expression and apoptosis characterize germ cell tumor (GCT) differentiation and progression. Proc Am Soc Clin Oncol 19:660a,2000,"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.707"},{"key":"R33","unstructured":"Bosl GJ, Geller NL, Cirrincione C, et al: Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43:3403,1983\u20133407,"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1762"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013275706401"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Skirnisdottir I, Sorbe B, Karlsson M, et al: Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma. Int J Oncol 19:1295,2001\u20131302,","DOI":"10.3892\/ijo.19.6.1295"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.22.3775"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1711::AID-CNCR10>3.0.CO;2-L"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.1026"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.261"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<828::AID-IJC23>3.0.CO;2-N"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)64571-3"},{"key":"R43","unstructured":"Ulbright TM, Orazi A, deRiese W, et al: The correlation of p53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. Mod Pathol 7:64,1994\u201368,"},{"key":"R44","unstructured":"Eid H, Geczi I, Magori A, et al: Drug resistance and sensitivity of germ cell testicular tumors: Evaluation of clinical relevance of MDR1\/Pgp, p53, and metallothionein (MT) proteins. Anticancer Res 18:3059,1998\u20133064,"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1007\/s002400050165"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.25.14863"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2003.03.136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:22:12Z","timestamp":1653510132000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2003.03.136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,15]]},"references-count":44,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2003,7,15]]}},"alternative-id":["10.1200\/JCO.2003.03.136"],"URL":"https:\/\/doi.org\/10.1200\/jco.2003.03.136","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,15]]}}}